ILC Dover is expanding its Irish production footprint by opening a location in Blarney, County Cork, Ireland, creating up to 70 jobs over two years. The project is supported by the Irish Government through IDA Ireland.

The building will be operational in the first quarter of 2019 and outfitted with 4,000 square feet of ISO 7 clean room capacity and 6,500 square feet of Class 8, both dedicated to the company’s pharmaceutical and biopharmaceutical product lines. When at full production, the company expects to hire 60-70 new ILC Dover employees. The new roles will include management, production, quality, design and support.

Minister for Business, Enterprise & Innovation, Heather Humphreys T.D., said, “I am delighted to see ILC Dover expand its footprint in Cork.  Ireland’s reputation as a centre of manufacturing excellence continues to grow, due to our experience in this area but also the availability of talent and skills required to manage outsourced production on an international scale. Ireland is now a major player and a very attractive location for companies like ILC Dover to grow their operations and I look forward to a mutually beneficial partnership developing.”

Mary Buckley, executive director, IDA Ireland, said, “I welcome the news that this global leader in flexible containment solutions is to expand its production capabilities in Blarney creating up to 70 jobs. Manufacturing excellence in pharmaceutical and biopharmaceuticals is a hallmark of Ireland’s success in the sector and is one of the primary reasons as to why Ireland is home to 10 of the top 10 global pharmaceutical companies. Winning investment for regional locations is a key focus for IDA Ireland and the resulting increase in employment this expansion will create is very important and I wish the company every success here and will follow your progress with interest.” 

ILC Dover president and chief executive officer, Fran DiNuzzo, said, “The expansion of our production capabilities in Ireland will allow us to better serve our global customer base and strengthen our position as the leading single-use powder handling solutions provider to the global pharmaceutical and biopharmaceutical marketplace.”

Curtis Gingles, vice president and general manager of the company’s Pharmaceutical Division, said, “Clients of ILC Dover will be happy to see that we’re focused on providing additional capacity located in the region with expanded technical resources. The market for our products is experiencing incredible growth and this expansion will ensure we can keep up with the growing demand for the high-quality products used in manufacturing lifesaving therapies.”

In addition to production space, the new facility will contain state-of-the-art offices, meeting rooms and a product demonstration area for client visits.